Paushak (BOM:532742) Cyclically Adjusted Revenue per Share: ₹80.57 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532742 Paushak Ltd BOM:532742
78 GF Score
Price ₹786.25
GF Value ₹759.81
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Paushak Cyclically Adjusted Revenue per Share?

Paushak BOM:532742 -1.90% 78 Cyclically Adjusted Revenue per Share is ₹80.57 as of Jun. 2026. GuruFocus rates BOM:532742 with a GF Score™ of 78/100 and a GF Value™ of ₹759.81 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Paushak's adjusted revenue per share for the three months ended in Jun. 2026 was ₹33.918. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹80.57 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Paushak's average Cyclically Adjusted Revenue Growth Rate was 12.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Paushak was 14.10% per year. The lowest was 10.80% per year. And the median was 13.00% per year.

As of today (2026-09-03), Paushak's current stock price is ₹786.25. Paushak's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹80.57. Paushak's Cyclically Adjusted PS Ratio of today is 9.76.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Paushak was 31.88. The lowest was 4.93. And the median was 12.02.


Paushak  (BOM:532742) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Paushak's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=786.25/80.57
=9.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Paushak was 31.88. The lowest was 4.93. And the median was 12.02.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Paushak Cyclically Adjusted Revenue per Share Related Terms


Paushak Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Paushak's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paushak Cyclically Adjusted Revenue per Share Chart

Paushak Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.38 56.49 63.67 69.78 76.77

Paushak Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.66 73.83 75.23 76.77 80.57

BOM:532742 vs LIN, SHW, ECL: Cyclically Adjusted Revenue per Share Comparison

For the Specialty Chemicals subindustry, Paushak's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paushak Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Paushak's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Paushak's Cyclically Adjusted PS Ratio falls into.


BOM:532742
78GF Score
Paushak Ltd BOM:532742
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paushak Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Paushak's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=33.918/167.3573*167.3573
=33.918

Current CPI (Jun. 2026) = 167.3573.

Paushak Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 7.600 105.961 12.004
201612 7.712 105.196 12.269
201703 6.577 105.196 10.463
201706 6.874 107.109 10.741
201709 7.893 109.021 12.116
201712 11.332 109.404 17.335
201803 14.711 109.786 22.425
201806 11.826 111.317 17.780
201809 13.521 115.142 19.653
201812 15.504 115.142 22.535
201903 14.660 118.202 20.756
201906 14.541 120.880 20.132
201909 13.978 123.175 18.992
201912 15.531 126.235 20.590
202003 11.187 124.705 15.013
202006 13.080 127.000 17.236
202009 12.031 130.118 15.474
202012 16.376 130.889 20.939
202103 15.127 131.771 19.212
202106 9.267 134.084 11.567
202109 16.477 135.847 20.299
202112 13.786 138.161 16.699
202203 20.707 138.822 24.963
202206 20.397 142.347 23.981
202209 20.205 144.661 23.375
202212 22.613 145.763 25.963
202303 22.262 146.865 25.368
202306 19.718 150.280 21.959
202309 21.093 151.492 23.302
202312 21.006 152.924 22.989
202403 21.257 153.035 23.246
202406 21.087 155.789 22.653
202409 23.252 157.882 24.647
202412 19.981 158.323 21.121
202503 21.272 157.552 22.596
202506 22.668 159.755 23.747
202509 23.843 162.289 24.588
202512 19.773 163.281 20.267
202603 22.347 164.272 22.767
202606 33.918 167.357 33.918

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹80.57 mean?
Paushak (BOM:532742) has a Cyclically Adjusted Revenue per Share of ₹80.57 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Paushak and its competitors.
Is Paushak's Cyclically Adjusted Revenue per Share too high?
Paushak's current Cyclically Adjusted Revenue per Share is ₹80.57. Overall, Paushak has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Paushak's Cyclically Adjusted Revenue per Share compare to LIN and SHW?
Paushak's Cyclically Adjusted Revenue per Share of ₹80.57 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Chemicals company?
A good Cyclically Adjusted Revenue per Share depends on the Chemicals industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Paushak and its competitors. Paushak's current Cyclically Adjusted Revenue per Share is ₹80.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paushak stock overvalued right now?
Based on GuruFocus' analysis, Paushak (BOM:532742) is currently considered Fairly Valued. The stock's GF Value™ is ₹759.81, compared to a current price of ₹786.25 — trading 3.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹80.57. Paushak's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Paushak (BOM:532742), the current Cyclically Adjusted Revenue per Share is ₹80.57 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Paushak (BOM:532742) Overvalued in 2026?

Based on GuruFocus' analysis, Paushak stock appears to be overvalued. The current stock price of ₹786.25 is trading 3.5% above its estimated GF Value™ of ₹759.81. GuruFocus considers Paushak to be Fairly Valued.

Key valuation signals for BOM:532742:

  • Cyclically Adjusted Revenue per Share: ₹80.57
  • GF Value™: ₹759.81 vs. price of ₹786.25 (3.5% above fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the BOM:532742 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Paushak Business Description

Other Exchanges PAUSHAKLTD:India
Address Alembic Road, Vadodara, GJ, IND, 390003
Paushak Ltd manufactures and develops phosgene-based specialty chemicals and intermediates. The company operates in only one segment, Speciality chemicals. It produces Isocyanates such as 2-Phenyl Ethyl isocyanate, Cyclohexyl isocyanate; Chloroformates which include Benzyl chloroformate, 2- Ethylhexyl chloroformate, Isobutyl chloroformate and Carboamoyl Chlorides such as Diethylcarbamoyl Chloride, and N-Ethyl-N-Methylcarbamoyl Chloride and others. Geographically, the company has a business presence in India and outside India, from which a majority of its revenue is derived within India.
78GF Score

Get the complete analysis for BOM:532742

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹786.25
Price
₹759.81
GF Value